RxDoctor Payments Data
★ My doctorsLook up a doctor →

Nicholas Robert

Hematology & Oncology · Fairfax, VANPI 1992772925

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $863 of the $995 with a category attached, or 86.7%. E.r. Squibb & Sons, L.L.C. accounts for 86.7% of it on its own, with 1 other manufacturer making up the rest. That places this record below the midpoint for hematology & oncology clinicians in VA, where the typical reported total is $1,232.

$995in general payments, 2019–2025

Across 2 payments — averaging $497.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$863
  • Seagen Inc.$132
$960,116in research payments, 2019–2025

Across 30 payments — averaging $32,004 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AstraZeneca$492K
  • Merck$357K
  • Pfizer$108K
  • Regeneron$3K
  • Medivation LLC.$185

What the payments were for

  • Consulting fees$86387%
  • Food & beverage$13213%

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
E.r. Squibb & Sons, L.L.C.1$863
Seagen Inc.1$132

How this compares

$995 in reported general payments places this provider in the 45th percentile of 293 hematology & oncology providers in Virginia.

See all hematology & oncology providers in Virginia →

Other hematology & oncology in Fairfax

See the full list for Virginia →

Where these figures come from

Is this you, or does something look wrong? →